Ndembe, Gloriana
Intini, Ilenia
Moro, Massimo
Grasselli, Chiara
Panfili, Andrea
Panini, Nicolò
Bleve, Augusto
Occhipinti, Mario
Borzi, Cristina
Garassino, Marina Chiara
Marabese, Mirko
Canesi, Simone
Scanziani, Eugenio
Sozzi, Gabriella
Broggini, Massimo http://orcid.org/0000-0002-8138-9358
Ganzinelli, Monica
Funding for this research was provided by:
Fondazione AIRC per la ricerca sul cancro ETS (IG 2017-20085, IG 2020-24347)
Article History
Received: 7 September 2023
Accepted: 11 December 2023
First Online: 2 January 2024
Declarations
:
: The IRFMN adheres to the principles set out in the following laws, regulations, and policies governing the care and use of laboratory animals: Italian Governing Law (D.lgs 26/2014; Authorisation n.19/2008-A issued March 6, 2008 by Ministry of Health); Mario Negri Institutional Regulations and Policies providing internal authorisation for persons conducting animal experiments (Quality Management System Certificate – UNI EN ISO 9001:2015 – Reg. N° 6121); the NIH Guide for the Care and Use of Laboratory Animals (2011 edition) and EU directives and guidelines (EEC Council Directive 2010/63/UE).
: Not applicable.
: M.C. Garassino reports grants and personal fees from Astra Zeneca, Merck; personal fees from BMS, Roche, Daiichi Sankyo, Celgene, GSK, Eli Lilly, Novartis, and personal fees from Regerenon during the conduct of the study.